A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Medtecs & TSMC Charity Foundation to Donate PPE to Taiwan’s 3 allies in Africa & the Americas

On February 20, 2021, in conjunction with Taiwan’s Ministry of Foreign Affairs, Medtecs Group, a leading personal protective equipment (PPE) supplier headquartered in Taiwan, donated coveralls, isolation gowns and other COVID-19-related PPE to the Kingdom of Eswatini, the Republic of Somaliland and the Commonwealth of Saint Lucia in partnership with TSMC Charity Foundation. The donation was designed to help the Taiwan government fulfill its Taiwan Can Help pledge.

Given Taiwan’s outstanding performance in containing COVID-19 and the relatively abundant supply of protective equipment and clothing locally, Medtecs decided to join forces with the TSMC Charity Foundation to support the Taiwan Can Help diplomatic initiative in conjunction with Taiwan’s Ministry of Foreign Affairs by identifying and assisting countries that were in need of PPE. The donation comprised 150,000 surgical masks, 7,000 coveralls, 11,000 isolation gowns, 6,000 caps, 6,000 sets of shoe covers and 1,500 CoverU Jackes (flight suits). The items will be distributed across the three countries, all of which are struggling to cope with the COVID-19 crisis. TSMC Charity Foundation had generously paid for the shipping costs of the donated goods.

“Medtecs has been the leading partner and prime vendor for Taiwan government’s national stockpiles of strategic goods, including PPE, for more than 10 years, and we are honored to be given the opportunity to join in the government’s efforts to help combat COVID-19 worldwide,” said Medtecs CEO William Yang. “Medtecs has long dedicated itself to creating value not just for our shareholders but for communities where we have operations and offices. Now we’re taking a step further and expanding our humanitarian reach by working side-by-side with the Ministry of Foreign Affairs and the TSMC Charity Foundation to coordinate and sponsor the donation of Medtecs’s safety products and protective clothing at an international level. In particular, we would like to thank Chairperson of the Foundation, Ms Sophie Chang, for her advice and for sharing her experiences in corporate philanthropy.”

Medtecs has always been at the forefront of the fight against viral outbreaks, be it SARS (2003), H1N1 (2009) or Ebola (2014). Ever since the onset of the COVID-19 pandemic in early 2020, the Group has mobilized its resources and distribution centers around the world to provide much needed PPE to over 30 countries, including United States, Germany, Italy, Cambodia, Taiwan and the Philippines, to just name a few. To date, Medtecs has donated over 5 million medical-grade face masks as well as more than 30,000 isolation gowns, and 20,000 coveralls, among other health products, to under-resourced communities and regions worldwide.

This round of donations to the Kingdom of Eswatini, the Republic of Somaliland and the Commonwealth of Saint Lucia is but another example of  Medtecs’s commitment to safeguarding the health and safety of humanity by providing effective and comfortable protective clothing and equipment through a resilient supply chain.

“With uncertainty surrounding the vaccine roll-out in different parts of the world, high-quality, top performing PPE remains the most direct and effective tool for minimizing the risk of infection and controlling the pandemic,” added Mr. Yang.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Under a license agreement, Biopredic will leverage Preci’s expertise and production capacity in sourcing primary hepatocytes, and combine with its own IP and know-how in cell pooling. The partnership will provide DMPK researchers access to large batches of high-performing suspended pooled hepatocytes with extended longevity from multiple donors.
The future of biotechnology holds immense promise, with continued advancements driving innovation and progress across various sectors. From gene editing and synthetic biology to biopharmaceuticals and beyond, the possibilities are endless. By staying informed, collaborating with industry leaders, and leveraging cutting-edge technologies, we can harness the power of biotechnology to address some of the most pressing challenges facing humanity.
"In a medical first, we have now dosed our first patient in a clinical trial using their own lymph nodes as living bioreactors to regenerate an ectopic organ," said Dr. Michael Hufford, Co-Founder and CEO of LyGenesis. "This therapy will potentially be a remarkable regenerative medicine milestone by helping patients with ESLD grow new functional ectopic livers in their own body. If our study is successful and we obtain FDA approval, our allogenic cell therapy could enable one donated liver to treat many dozens of ESLD patients, which could help to tilt the current organ supply-demand imbalance in favor of patients."
The relationship between pharmaceutical companies and CDMOs is fundamentally collaborative, fostering an environment of innovation. By partnering with a CDMO, pharmaceutical firms can access a wide array of technologies and expertise that might otherwise be beyond their reach.
Serum Detect is developing diagnostic tests, using standard liquid biopsy samples, that complement and enhance existing screening techniques for early detection of cancer.

By using this website you agree to accept Medical Device News Magazine Privacy Policy